{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:12:47Z","timestamp":1769598767674,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016096","name":"Shanghai Key Basic Research Program","doi-asserted-by":"publisher","award":["SHDC2023CRT014"],"award-info":[{"award-number":["SHDC2023CRT014"]}],"id":[{"id":"10.13039\/100016096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202440091"],"award-info":[{"award-number":["202440091"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["20220103"],"award-info":[{"award-number":["20220103"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Shanghai Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["24ZR1448600"],"award-info":[{"award-number":["24ZR1448600"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230040"],"award-info":[{"award-number":["82230040"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341251"],"award-info":[{"award-number":["82341251"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.nbd.2025.107083","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T16:06:14Z","timestamp":1756915574000},"page":"107083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dynamic cortical inhibition imbalance as a biomarker of clinical progression in early Parkinson's disease"],"prefix":"10.1016","volume":"215","author":[{"given":"Puyu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningdi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianyi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liche","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.nbd.2025.107083_bb0005","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1093\/brain\/awaa274","article-title":"Cortical disinhibition in Parkinson\u2019s disease","volume":"143","author":"Ammann","year":"2020","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.nbd.2025.107083_bb0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1468-1331.2003.00610.x","article-title":"Intracortical inhibition and facilitation are impaired in patients with early Parkinson\u2019s disease: a paired TMS study","volume":"10","author":"Bares","year":"2003","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.nbd.2025.107083_bb0015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00221-007-0866-7","article-title":"Laterality of interhemispheric inhibition depends on handedness","volume":"180","author":"B\u00e4umer","year":"2007","journal-title":"Exp. Brain Res."},{"issue":"7","key":"10.1016\/j.nbd.2025.107083_bb0020","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0000000000004232","article-title":"Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia","volume":"89","author":"Benussi","year":"2017","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nbd.2025.107083_bb0025","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.brs.2019.11.009","article-title":"TMS for staging and predicting functional decline in frontotemporal dementia","volume":"13","author":"Benussi","year":"2020","journal-title":"Brain Stimul."},{"issue":"6","key":"10.1016\/j.nbd.2025.107083_bb0030","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1471-4159.2011.07376.x","article-title":"Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels","volume":"118","author":"Bido","year":"2011","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.nbd.2025.107083_bb0035","doi-asserted-by":"crossref","first-page":"14781","DOI":"10.1038\/s41598-021-94255-9","article-title":"The severity progression of non-motor symptoms in Parkinson\u2019s disease: a 6-year longitudinal study in Taiwanese patients","volume":"11","author":"Chen","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.nbd.2025.107083_bb0040","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00221-007-1125-7","article-title":"Possible differences between the time courses of presynaptic and postsynaptic GABAB mediated inhibition in the human motor cortex","volume":"184","author":"Chu","year":"2008","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.nbd.2025.107083_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2020.02.028","article-title":"Initial motor reserve and long-term prognosis in Parkinson\u2019s disease","volume":"92","author":"Chung","year":"2020","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.nbd.2025.107083_bb0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ene.13412","article-title":"Atypical parkinsonian syndromes: a general neurologist\u2019s perspective","volume":"25","author":"Deutschlander","year":"2018","journal-title":"Eur. J. Neurol."},{"issue":"10","key":"10.1016\/j.nbd.2025.107083_bb0055","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/mds.28682","article-title":"Asymmetric dopamine transporter loss affects cognitive and motor progression in Parkinson\u2019s disease","volume":"36","author":"Fiorenzato","year":"2021","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.nbd.2025.107083_bb0060","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1113\/jphysiol.2007.142059","article-title":"Inhibitory circuits and the nature of their interactions in the human motor cortex a pharmacological TMS study","volume":"586","author":"Florian","year":"2008","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.nbd.2025.107083_bb0065","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ana.410340331","article-title":"Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson\u2019s disease","volume":"34","author":"Frost","year":"1993","journal-title":"Ann. Neurol."},{"issue":"Suppl. 2","key":"10.1016\/j.nbd.2025.107083_bb0070","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1007\/s100720200078","article-title":"Clinical predictors in Parkinson\u2019s disease","volume":"23","author":"Gasparoli","year":"2002","journal-title":"Neurol. Sci."},{"issue":"9","key":"10.1016\/j.nbd.2025.107083_bb0075","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement Disorder Society task force report on the Hoehn and Yahr staging scale: status and recommendations","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.nbd.2025.107083_bb0080","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/jmri.25865","article-title":"Inhibitory motor dysfunction in parkinson\u2019s disease subtypes","volume":"47","author":"Gong","year":"2018","journal-title":"J. Magn. Reson. Imaging"},{"issue":"1","key":"10.1016\/j.nbd.2025.107083_bb0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/mds.29266","article-title":"The concept of Motor Reserve in Parkinson\u2019s disease: new wine in old bottles?","volume":"38","author":"Hoenig","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107083_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.106101","article-title":"Brain-first vs. body-first Parkinson\u2019s disease: an update on recent evidence","volume":"122","author":"Horsager","year":"2024","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.nbd.2025.107083_bb0095","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/mds.28312","article-title":"Differences in the presentation and progression of Parkinson\u2019s disease by sex","volume":"36","author":"Iwaki","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107083_bb0100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbi.2025.06.026","article-title":"Sex differences in neurological disorders: insights from ischemic stroke, Parkinson\u2019s disease, and multiple sclerosis","volume":"129","author":"Kaufhold","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.nbd.2025.107083_bb0105","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.neucli.2021.08.002","article-title":"Are there differences in cortical excitability between akinetic-rigid and tremor-dominant subtypes of Parkinson\u2019s disease?","volume":"51","author":"Khedr","year":"2021","journal-title":"Neurophysiol. Clin."},{"issue":"4","key":"10.1016\/j.nbd.2025.107083_bb0110","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.clinph.2016.01.022","article-title":"Changes in intracortical inhibition and clinical symptoms after STN-DBS in Parkinson\u2019s disease","volume":"127","author":"Kobayashi","year":"2016","journal-title":"Clin. Neurophysiol."},{"issue":"8","key":"10.1016\/j.nbd.2025.107083_bb0115","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/mds.26167","article-title":"Transcranial magnetic stimulation follow-up study in early Parkinson\u2019s disease: a decline in compensation with disease progression?","volume":"30","author":"Kojovic","year":"2015","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.nbd.2025.107083_bb0120","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/ner.12690","article-title":"Motor cortical plasticity relates to symptom severity and clinical benefit from deep brain stimulation in cervical dystonia","volume":"21","author":"Kroneberg","year":"2018","journal-title":"Neuromodulation"},{"key":"10.1016\/j.nbd.2025.107083_bb0125","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1113\/jphysiol.1993.sp019912","article-title":"Corticocortical inhibition in human motor cortex","volume":"471","author":"Kujirai","year":"1993","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2025.107083_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2024.120701","article-title":"Distinct patterns of electrophysiologic-neuroimaging correlations between Parkinson\u2019s disease and multiple system atrophy","volume":"297","author":"Li","year":"2024","journal-title":"Neuroimage"},{"issue":"7","key":"10.1016\/j.nbd.2025.107083_bb0135","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14874","article-title":"Exploring brain asymmetry in early-stage Parkinson\u2019s disease through functional and structural MRI","volume":"30","author":"Liu","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.nbd.2025.107083_bb0140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1212\/WNL.46.1.231","article-title":"[123I] beta-CIT\/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson\u2019s disease","volume":"46","author":"Marek","year":"1996","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.nbd.2025.107083_bb0145","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/mds.26107","article-title":"The significance of motor (a)symmetry in Parkinson\u2019s disease","volume":"30","author":"Marinus","year":"2015","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.nbd.2025.107083_bb0150","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00221-006-0365-2","article-title":"The role of GABA(B) receptors in intracortical inhibition in the human motor cortex","volume":"173","author":"McDonnell","year":"2006","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.nbd.2025.107083_bb0155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jns.2018.08.001","article-title":"Motor asymmetry over time in Parkinson\u2019s disease","volume":"393","author":"Miller-Patterson","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2025.107083_bb0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0074-7742(08)60304-9","article-title":"The pharmacology and function of central GABAB receptors","volume":"36","author":"Mott","year":"1994","journal-title":"Int. Rev. Neurobiol."},{"issue":"2","key":"10.1016\/j.nbd.2025.107083_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020590","article-title":"TGF-\u03b2\/Smad3 Signalling modulates GABA neurotransmission: implications in Parkinson\u2019s disease","volume":"21","author":"Mu\u00f1oz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"Pt 3","key":"10.1016\/j.nbd.2025.107083_bb0170","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1113\/jphysiol.1997.sp021905","article-title":"Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans","volume":"498","author":"Nakamura","year":"1997","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107083_bb0175","doi-asserted-by":"crossref","first-page":"fcae020","DOI":"10.1093\/braincomms\/fcae020","article-title":"Interhemispheric imbalance and bradykinesia features in Parkinson\u2019s disease","volume":"6","author":"Paparella","year":"2024","journal-title":"Brain Commun."},{"issue":"11","key":"10.1016\/j.nbd.2025.107083_bb0180","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1093\/brain\/awae210","article-title":"Neurophysiological markers of motor compensatory mechanisms in early Parkinson\u2019s disease","volume":"147","author":"Passaretti","year":"2024","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.nbd.2025.107083_bb0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s002210100839","article-title":"Effect of apomorphine on cortical inhibition in Parkinson\u2019s disease patients: a transcranial magnetic stimulation study","volume":"141","author":"Pierantozzi","year":"2001","journal-title":"Exp. Brain Res."},{"issue":"2","key":"10.1016\/j.nbd.2025.107083_bb0190","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.410370208","article-title":"Changes in excitability of motor cortical circuitry in patients with Parkinson\u2019s disease","volume":"37","author":"Ridding","year":"1995","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.nbd.2025.107083_bb0195","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/ejn.12840","article-title":"Parietal transcranial direct current stimulation modulates primary motor cortex excitability","volume":"41","author":"Rivera-Urbina","year":"2015","journal-title":"Eur. J. Neurosci."},{"issue":"14","key":"10.1016\/j.nbd.2025.107083_bb0200","doi-asserted-by":"crossref","first-page":"e1413","DOI":"10.1212\/WNL.0000000000012662","article-title":"Changes in cortical excitability and Parkinson tremor after botulinum toxin therapy","volume":"97","author":"Samotus","year":"2021","journal-title":"Neurology"},{"issue":"Pt 2","key":"10.1016\/j.nbd.2025.107083_bb0205","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1469-7793.2001.0307l.x","article-title":"Interactions between two different inhibitory systems in the human motor cortex","volume":"530","author":"Sanger","year":"2001","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107083_bb0210","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13578-023-01105-4","article-title":"Sex-dependent neuronal effects of \u03b1-synuclein reveal that GABAergic transmission is neuroprotective of sleep-controlling neurons","volume":"13","author":"Santos","year":"2023","journal-title":"Cell Biosci."},{"issue":"13","key":"10.1016\/j.nbd.2025.107083_bb0215","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1002\/mds.22025","article-title":"Motor cortical physiology in patients and asymptomatic carriers of parkin gene mutations","volume":"23","author":"Schneider","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107083_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112224","article-title":"\u0393-aminobutyric acid in adult brain: an update","volume":"376","author":"Siucinska","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2025.107083_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117309","article-title":"Single-dose L-dopa increases upper brainstem GABA in Parkinson\u2019s disease: a preliminary study","volume":"422","author":"Song","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.nbd.2025.107083_bb0230","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.brs.2013.05.004","article-title":"Interhemispheric balance in Parkinson\u2019s disease: a transcranial magnetic stimulation study","volume":"6","author":"Spagnolo","year":"2013","journal-title":"Brain Stimul."},{"issue":"7","key":"10.1016\/j.nbd.2025.107083_bb0235","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S1388-2457(00)00316-3","article-title":"Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson\u2019s disease: a transcranial magnetic stimulation study","volume":"111","author":"Strafella","year":"2000","journal-title":"Clin. Neurophysiol."},{"issue":"4","key":"10.1016\/j.nbd.2025.107083_bb0240","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.3233\/JPD-202117","article-title":"Hemispheric network expression in Parkinson\u2019s disease: relationship to dopaminergic asymmetries","volume":"10","author":"Tang","year":"2020","journal-title":"J. Parkinsons Dis."},{"issue":"4","key":"10.1016\/j.nbd.2025.107083_bb0245","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hbm.24857","article-title":"GABAergic changes in the thalamocortical circuit in Parkinson\u2019s disease","volume":"41","author":"van Nuland","year":"2020","journal-title":"Hum. Brain Mapp."},{"issue":"7","key":"10.1016\/j.nbd.2025.107083_bb0250","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","article-title":"Progress towards therapies for disease modification in Parkinson\u2019s disease","volume":"20","author":"Vijiaratnam","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.107083_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropsychologia.2022.108419","article-title":"Biomarkers and non-motor symptoms as a function of motor symptom asymmetry in early Parkinson\u2019s disease","volume":"177","author":"Voruz","year":"2022","journal-title":"Neuropsychologia"},{"issue":"Pt 2","key":"10.1016\/j.nbd.2025.107083_bb0260","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1469-7793.1999.0591t.x","article-title":"Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans","volume":"517","author":"Werhahn","year":"1999","journal-title":"J. Physiol."},{"issue":"8","key":"10.1016\/j.nbd.2025.107083_bb0265","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.2967\/jnumed.110.076802","article-title":"Progression from unilateral to bilateral parkinsonism in early Parkinson disease: implication of mesocortical dopamine dysfunction by PET","volume":"51","author":"Yagi","year":"2010","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.nbd.2025.107083_bb0270","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/mds.22875","article-title":"Progression of Parkinson\u2019s disease as evaluated by Hoehn and Yahr stage transition times","volume":"25","author":"Zhao","year":"2010","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.nbd.2025.107083_bb0275","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.clinph.2014.08.028","article-title":"TMS and drugs revisited 2014","volume":"126","author":"Ziemann","year":"2015","journal-title":"Clin. Neurophysiol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125003006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125003006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:24:59Z","timestamp":1759299899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125003006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":55,"alternative-id":["S0969996125003006"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107083","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamic cortical inhibition imbalance as a biomarker of clinical progression in early Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107083"}}